Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2017 / Article

Case Report | Open Access

Volume 2017 |Article ID 2891510 | 4 pages | https://doi.org/10.1155/2017/2891510

Melioidosis with Portal Vein Thrombosis

Academic Editor: Gernot Walder
Received05 Feb 2017
Accepted27 Mar 2017
Published03 Apr 2017

Abstract

Melioidosis, caused by Burkholderia pseudomallei, is a common infectious disease in tropical regions. The author reports a case of melioidosis with a rare manifestation of portal vein thrombosis and cavernous transformation of the portal vein. Melioidosis should be considered a differential diagnosis in patients with underlying risk factors who present with multiple liver abscesses; moreover, portal vein thrombosis can be a potential complication. Computed tomography is the modality of choice to demonstrate venous thrombosis in various organs.

1. Introduction

Melioidosis, caused by Burkholderia pseudomallei, is a common infectious disease in tropical and subtropical regions and is especially endemic in Southeast Asia [1]. Since 1997, the number of melioidosis cases diagnosed in Thailand has been increasing [2], with approximately 1,000 deaths per year [3]. The lung is the most commonly affected organ [4, 5], and the spleen is the most commonly affected intra-abdominal organ, followed by the liver and the kidney [6]. Computed tomography (CT) can reveal the radiologic characteristics of melioid abscesses such as the “necklace sign” or the “honeycomb sign” [7]. The author reports here a case of melioidosis with a rare manifestation of portal vein thrombosis.

2. Case Presentation

A written informed consent was obtained from the patient for publication of this case report and all accompanying images.

An otherwise healthy 54-year-old Thai farmer, a resident in Nakhon Si Thammarat, visited the emergency department because of persistent fever with right upper abdominal pain for 1 month. He had no medical or surgical history of note, in particular, and no known history of diabetes or immunosuppression. He sought local care and was given oral antibiotics and antipyretics, but his condition had not improved.

On arrival, he was febrile, icteric, and dehydrated. His body temperature was 38.9°C, blood pressure was 100/70 mmHg, respiratory rate was 30/min, and heart rate was 110/min. The liver was mildly enlarged. No cardiovascular or respiratory abnormality was found on physical examination.

Laboratory analysis showed the following: leukocytosis (total leukocyte count, 16,700 cells/mm3; segmented neutrophils, 80%); fasting blood sugar, 202 mg/dl; glycosylated hemoglobin (HbA1c), 12.8%; total bilirubin, 4.74 mg/dl; direct bilirubin, 3.49 mg/dl; alkaline phosphatase, 553 U/L; serum glutamic-oxaloacetic transaminase (SGOT), 27 U/L; and serum glutamic-pyruvic transaminase (SGPT), 39 U/L. Serum total protein and albumin levels were 7.2 and 3.6 g/dl, respectively. Results of coagulation tests of prothrombin time (PT) and international normalized ratio (INR) were within normal limits. Blood culture results showed Burkholderia pseudomallei.

His CT study showed multiple small liver abscesses, left portal vein thrombosis, and cavernous transformation of the portal vein (Figures 1 and 2). His pancreas and spleen appeared normal. Gallbladder wall congestion and periportal halo were also noted (Figure 3). The chest radiograph showed no pulmonary infiltration or nodule.

The treatment comprised an initial 2-week acute-phase intravenous therapy consisting of ceftazidime and metronidazole, followed by oral amoxicillin-clavulanic acid for 12 weeks, in addition to anticoagulants (daily subcutaneous injections of low molecular weight heparin). Percutaneous abscess drainage was not performed because of small abscesses and the patient’s positive response to antibiotics. Improvements in the patient’s abdominal pain and blood test results were obtained. A follow-up CT scan was done after 8 weeks of treatment, showing a completely recanalized left portal vein. At the 10-month follow-up after completion of the antibiotic course, the patient had totally recovered and no relapse had been documented. The patient was advised to avoid direct contact with soil or environmental water, to protect wounds from soil and water, and to avoid walking barefoot.

3. Discussion

Burkholderia pseudomallei (formerly, Pseudomonas pseudomallei) is a bipolar-staining, Gram-negative aerobic bacillus and is found in tropical regions. Melioidosis occurs more frequently in patients with underlying diseases, such as diabetes, chronic renal failure, alcoholism, malignancy, and hematological diseases, including immunosuppression. This patient was first diagnosed with diabetes in this visit and it was noted that he worked as a farmer who sometimes walked barefoot on his cultivated land.

The author reports a case of melioidosis with a rare manifestation of portal vein thrombosis and cavernous transformation diagnosed based on CT findings. There are a few reported cases of melioidosis-associated venous thrombosis. Saïdani et al. [8] reported a case of disseminated melioidosis with pulmonary and liver abscesses, in addition to splenic vein thrombosis. Splenic vein thrombosis is also described in cases of melioidosis associated with pancreatic lesions [9]. Niyasom et al. [10] reported a 42-year-old Thai man suffering from septicemic melioidosis with dural sinus thrombosis. The thrombotic events were possibly caused by an inflammatory response to systemic B. pseudomallei infection, leading to depletion of the natural endothelial modulators protein C, protein S, and antithrombin [10, 11]. LaRosa et al. [11] studied the correlation between inflammation and coagulation in melioidosis sepsis, revealing that consumption of endothelial modulators was a key feature of this process. Protein C was the modulator most profoundly affected, followed by antithrombin and protein S.

Cavernous transformation of the portal vein is a consequence of portal vein thrombosis and is the replacement of the normal single channel portal vein with numerous tortuous venous channels. Multiphase CT can be used to confirm the diagnosis as it demonstrates numerous vascular structures in the region of the portal vein, which are enhanced during the portal venous phase.

Saverymuttu et al. [12] reported that portal hypertension, not hypoalbuminemia, was the dominant factor causing gallbladder wall thickening in chronic liver disease. The CT image (Figure 3) showed gallbladder wall congestion (so-called congestive cholecystopathy) and a periportal halo. Periportal halos are defined as circumferential zones of low attenuation around the peripheral or subsegmental portal venous branches on contrast-enhanced CT. These halos represent fluid or dilated lymphatics in the loose areolar zone around the portal triad. This sign is nonspecific and can be seen in various conditions.

Transient hepatic attenuation differences (THAD) are localized mismatches in hepatic arterial and portal venous blood supply; often there is a relative increase in hepatic arterial supply, thereby giving a higher attenuation to the affected region. In this case the CT demonstrated higher attenuation in the left lobe of the liver than in the right lobe owing to left portal vein thrombosis.

Various causative organisms have been reported as causing portal vein thrombosis (Table 1).


Causative organismsPresentation

Cytomegalovirus (CMV) [1315]Acute CMV-related hepatitis with PVT
Mycobacterial tuberculosis [16]Peritoneal tuberculosis with PVT
Vancomycin resistant Staphylococcus aureus (VRSA) [17]VRSA mandibular osteomyelitis and PVT with hepatic abscess
Group C streptococcus [18]Sigmoid diverticulitis with PVT
Escherichia coli [19]Sigmoid diverticulitis with PVT
Fusobacterium necrophorum [20]Acute attack on chronic pancreatitis with PVT and multiple hepatic abscesses

4. Conclusion

Melioidosis should be considered as a differential diagnosis in patients with underlying risk factors who present with multiple liver abscesses; portal vein thrombosis can be a potential complication. Contrast-enhanced CT scan is the modality of choice to identify venous thrombosis in various organs.

Conflicts of Interest

The author declares that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

The author would like to thank the staff of the School of Medicine, Walailak University, for their support.

References

  1. N. J. White, “Melioidosis,” The Lancet, vol. 361, no. 9370, pp. 1715–1722, 2003. View at: Publisher Site | Google Scholar
  2. D. Limmathurotsakul, S. Wongratanacheewin, N. Teerawattanasook et al., “Increasing incidence of human melioidosis in northeast Thailand,” The American Journal of Tropical Medicine and Hygiene, vol. 82, no. 6, pp. 1113–1117, 2010. View at: Publisher Site | Google Scholar
  3. P. Chansrichavala, N. Wongsuwan, S. Suddee et al., “Public awareness of Melioidosis in Thailand and potential use of video clips as educational tools,” PLoS ONE, vol. 10, no. 3, Article ID e0121311, 2015. View at: Publisher Site | Google Scholar
  4. A. C. Cheng and B. J. Currie, “Melioidosis: epidemiology, pathophysiology, and management,” Clinical Microbiology Reviews, vol. 18, no. 2, pp. 383–416, 2005. View at: Publisher Site | Google Scholar
  5. B. J. Currie, S. P. Jacups, A. C. Cheng et al., “Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia,” Tropical Medicine and International Health, vol. 9, no. 11, pp. 1167–1174, 2004. View at: Publisher Site | Google Scholar
  6. B. J. Currie, L. Ward, and A. C. Cheng, “The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study,” PLoS Neglected Tropical Diseases, vol. 4, no. 11, article e900, 2010. View at: Publisher Site | Google Scholar
  7. P. Apisarnthanarak, A. Thairatananon, K. Muangsomboon, D. S. K. Lu, L. M. Mundy, and A. Apisarnthanarak, “Computed tomography characteristics of hepatic and splenic abscesses associated with melioidosis: a 7-year study,” Journal of Medical Imaging and Radiation Oncology, vol. 55, no. 2, pp. 176–182, 2011. View at: Publisher Site | Google Scholar
  8. N. Saïdani, K. Griffiths, M. Million et al., “Melioidosis as a travel-associated infection: case report and review of the literature,” Travel Medicine and Infectious Disease, vol. 13, no. 5, pp. 367–381, 2015. View at: Publisher Site | Google Scholar
  9. V. H. Chong, K. S. Lim, and F. Sharif, “Pancreatic involvement in melioidosis,” Journal of the Pancreas, vol. 11, no. 4, pp. 365–368, 2010. View at: Google Scholar
  10. S. Niyasom, P. Sithinamsuwan, C. Udommongkol, and J. Suwantamee, “Dural sinus thrombosis in melioidosis: the first case report,” Journal of the Medical Association of Thailand, vol. 89, no. 2, pp. 242–247, 2006. View at: Google Scholar
  11. S. P. LaRosa, S. M. Opal, B. Utterback et al., “Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei,” International Journal of Infectious Diseases, vol. 10, no. 1, pp. 25–31, 2006. View at: Publisher Site | Google Scholar
  12. S. H. Saverymuttu, A. Grammatopoulos, C. I. Meanock, J. D. Maxwell, and A. E. A. Joseph, “Gallbladder wall thickening (congestive cholecystopathy) in chronic liver disease: a sign of portal hypertension,” British Journal of Radiology, vol. 63, no. 756, pp. 922–925, 1990. View at: Publisher Site | Google Scholar
  13. A. Galloula, A. Rossi, V. Gautier, C. Minozzi, E. Messas, and T. Mirault, “Portal vein thrombosis associated with an acute cytomegalovirus infection,” Journal des Maladies Vasculaires, vol. 39, no. 3, pp. 224–230, 2014. View at: Publisher Site | Google Scholar
  14. F. Chelbi, D. Boutin-Le Thi Huong, M. Frigui, B. Asli, P. Hausfater, and J.-C. Piette, “Portal thrombosis complicating an acute cytomegalovirus infection in an immunocompetent patient,” La Revue de Médecine Interne, vol. 27, no. 1, pp. 54–58, 2006. View at: Publisher Site | Google Scholar
  15. J. L. Estival, P. Debourdeau, C. Zammit, L. Teixeira, S. Guérard, and B. Colle, “Spontaneous portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient,” Presse Medicale, vol. 30, no. 38, pp. 1876–1878, 2001. View at: Google Scholar
  16. U. M. Wariyapperuma and C. I. W. Jayasundera, “Peritoneal tuberculosis presenting with portal vein thrombosis and transudative Ascites—a diagnostic dilemma: case report,” BMC Infectious Diseases, vol. 15, no. 1, article 394, 2015. View at: Publisher Site | Google Scholar
  17. J. Kathwate and I. Shah, “Portal vein thrombosis as a complication of vancomycin resistant Staphylococcus aureas infection in an infant,” Sri Lankan Journal of Infectious Diseases, vol. 5, no. 1, pp. 28–31, 2015. View at: Publisher Site | Google Scholar
  18. E. Carnish, A. Garrett, and M. Slome, “A case of septic portal vein thrombosis (pylephlebitis),” The Medicine Forum, vol. 15, p. 21, 2015. View at: Google Scholar
  19. M. Gajendran, T. Muniraj, and M. Yassin, “Diverticulitis complicated by pylephlebitis: a case report,” Journal of Medical Case Reports, vol. 5, article 514, 2011. View at: Publisher Site | Google Scholar
  20. L. Shahani and N. Khardori, “Fusobacterium necrophorum—beyond Lemierres syndrome,” BMJ Case Reports, vol. 2011, 2011. View at: Publisher Site | Google Scholar

Copyright © 2017 Thanyaporn Direksunthorn. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

871 Views | 233 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.